The "YUNNAN BAIYAO" trademark, serial number 85030053 , was filed on 4th of May 2010 with a mark drawing code of 4000 and its transaction date is 85030053. The attorney assigned is Rod S. Berman, attorney docket number 61855-1002. Since 26th of March 2012, the document can be found in the L10 law office in the publication and issue section. The employee responsible is CLARK, ROBERT C and the date it was published for opposition on 05/29/2012. The status of the trademark was checked last on 03/26/2012.

The corresponded responsible for this trademark is ROD S. BERMAN, located at JEFFER, MANGELS, BUTLER & MARMARO LLP, 1900 AVENUE OF THE STARS FL 7, LOS ANGELES, CA 90067-4308.

The state or country where the trademark was organized is by Yunnan Baiyao Group Co., Ltd.. The legal entity type behing it is a Corporation, located at State High & New Technology Zone, Kunming, Yunnan, zip .

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	6 - Active
Status Date	05/10/2010
First Use Date	07/16/2003
First Use in Commerce Date	07/16/2003
Primary Code	005
Goods codes
GS0051	Medicated toothpaste; dietary food supplements; dietary and nutritional supplements; food supplements; nutritional drinks used for meal replacement; medicinal herbal preparation, processed ginseng, panax notoginseng, bee pollen, edible bird's nest, and propolis for medical purposes; herbal supplements; liquid nutritional supplements; medicinal preparations for human purposes, namely, medicinal preparations for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; pharmaceutical preparations and medicinal preparations in capsule form for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; pharmaceutical preparations for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; nervines, namely, nerve calming preparation and pharmaceutical preparations acting on the central nervous system; germicides; medicinal herbs in dried or preserved form; pharmaceutical styptic preparations; biological preparations for medical purposes; medical preparations for slimming purposes; medicines for dental purposes, namely, medicines for use in treatment of pain in the gums and periodontia; edible plant fibers, namely, plant extracts for medical and pharmaceutical purposes; raw medicines, namely, raw materials pharmaceuticals, namely, medicinal herbal extracts for medical purposes, vitamin and mineral preparations for use as ingredients in the pharmaceutical industry; medicinal herbal preparations for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; medicinal herbal preparations, namely, herbal ointments used for stopping bleeding, relieving pain and anti-inflammatory purposes; poultices; radioactive medicines, namely, radioactive substances for use in nuclear medicine; gases for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; sanitary sterilizing preparations; solutions for contact lenses; cultures of microorganisms for medical and veterinary use; dietetic foods adapted for medical purposes; dietetic food preparations adapted for medical purposes, namely, dietetic beverages for treatment of trace elements, namely, iron, zinc, and calcium deficiency diseases; nutritional additives for use in foods and dietary supplements for human consumption for medical purposes; infant formula, namely, infant milk powder; air purifying preparations, namely, air deodorizer and air freshening preparations; medicines for veterinary purposes, namely, veterinary preparations for treatment of intestinal bacteria, relieving pain, anti-infective and veterinary vaccines; pesticides; herbicides; sanitary towels, namely, sanitary napkins and sanitary pads; sterile paper towel, namely, medicated pre-moistened towelettes; adhesive plaster for medical purposes; gummed medical plasters; medical dressings, namely, gauze and cotton for medical purposes; surgical dressings; surgical tissues, namely, surgical dressings and surgical bandages; first-aid kits; teeth filling material, namely, fillings for teeth; analgesic preparations, namely, an external analgesic aerosol used for relieving pain and anti-inflammatory purposes; diet capsules; diet capsules in the nature of processed ginseng, panax notoginseng, bee pollen, and bird's nest used as an herbal supplement; pharmaceutical preparations, namely, appetite suppressants; nutritional supplements, namely, edible plant fibers for medical purposes in the nature of cereal fibers, xylogen and pectin
N00000	The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
TR0010	The wording Yunnan Baiyao has no meaning in a foreign language.

PROSECUTION HISTORY
Date	Description	Type	Code
08/14/2010	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
08/16/2010	NON-FINAL ACTION WRITTEN	R - Renewal	CNRT - NON-FINAL ACTION WRITTEN
05/10/2010	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
05/07/2010	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM
03/26/2012	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2012	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2012	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/29/2011	NOTIFICATION OF NON-FINAL ACTION E-MAILED	O - Outgoing Correspondence	GNRN
09/29/2011	NON-FINAL ACTION E-MAILED	O - Outgoing Correspondence	GNRT - NON-FINAL ACTION E-MAILED
09/29/2011	NON-FINAL ACTION WRITTEN	R - Renewal	CNRT - NON-FINAL ACTION WRITTEN
09/09/2011	EXAMINER'S AMENDMENT ENTERED	I - Incoming Correspondence	XAEC - EXAMINER'S AMENDMENT ENTERED
09/09/2011	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	O - Outgoing Correspondence	GNEN
09/09/2011	EXAMINERS AMENDMENT E-MAILED	O - Outgoing Correspondence	GNEA - EXAMINERS AMENDMENT E-MAILED
09/09/2011	EXAMINERS AMENDMENT -WRITTEN	R - Renewal	CNEA - EXAMINERS AMENDMENT -WRITTEN
03/09/2011	NOTIFICATION OF FINAL REFUSAL EMAILED	O - Outgoing Correspondence	GNFN
03/09/2011	FINAL REFUSAL E-MAILED	O - Outgoing Correspondence	GNFR - FINAL REFUSAL E-MAILED
03/09/2011	FINAL REFUSAL WRITTEN	R - Renewal	CNFR - FINAL REFUSAL WRITTEN
02/16/2011	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
02/15/2011	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
02/15/2011	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2010	NOTIFICATION OF NON-FINAL ACTION E-MAILED	O - Outgoing Correspondence	GNRN
08/16/2010	NON-FINAL ACTION E-MAILED	F - First Action	GNRT - NON-FINAL ACTION E-MAILED

Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.